Form 8-K - Current report:
SEC Accession No. 0001193125-24-222901
Filing Date
2024-09-20
Accepted
2024-09-20 16:11:57
Documents
14
Period of Report
2024-09-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d881365d8k.htm   iXBRL 8-K 34300
2 EX-10.1 d881365dex101.htm EX-10.1 40453
  Complete submission text file 0001193125-24-222901.txt   210542

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA veru-20240919.xsd EX-101.SCH 2848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20240919_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20240919_pre.xml EX-101.PRE 11260
17 EXTRACTED XBRL INSTANCE DOCUMENT d881365d8k_htm.xml XML 3656
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 241313501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)